Francis Lidgey
Direktor/Vorstandsmitglied bei Phibex Plc
Aktive Positionen von Francis Lidgey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Oxford Brookes University | Corporate Officer/Principal | 01.01.1992 | - |
| Phibex Plc | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Francis Lidgey
Ehemalige bekannte Positionen von Francis Lidgey
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NUFORMIX PLC | Direktor/Vorstandsmitglied | - | 31.01.2020 |
| Independent Dir/Board Member | - | 31.01.2020 | |
| LTP Electronics Ltd. | Direktor/Vorstandsmitglied | - | - |
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Levrett Plc
 Levrett Plc BiotechnologyHealth Technology Levrett Plc is a special purpose acquisition company. It is formed to acquire realizable and/or developed commercial technologies focused in the pharmaceutical and biotechnology sector. The company was founded on June 10, 2015 and is headquartered in London, the United Kingdom. | Vorsitzender | - | - |
Ausbildung von Francis Lidgey
| University of Surrey | Doctorate Degree |
| The University of Newcastle | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 8 |
| Australien | 2 |
Operativ
| Director/Board Member | 4 |
| Doctorate Degree | 2 |
| Chairman | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NUFORMIX PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Levrett Plc
Levrett Plc BiotechnologyHealth Technology Levrett Plc is a special purpose acquisition company. It is formed to acquire realizable and/or developed commercial technologies focused in the pharmaceutical and biotechnology sector. The company was founded on June 10, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Nuformix Technologies Ltd. engages in investment in pharmaceutical products. Its activities include development and discovery of patented novel cocrystal forms of approved small molecules, creating an IP portfolio containing 14 granted patents covering cocrystal forms of five small molecule drugs. It offers the NXP001 and NXP002. The company was founded by Dr. David Joszef Tapolzcay and Dr. Daniel Gooding on October 23, 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Phibex Plc | |
| LTP Electronics Ltd. |
- Börse
- Insiders
- Francis Lidgey
- Erfahrung
